F-group (family)
206.1.1.2 Pkinase,Pkinase_C
Ligands and drugs
408
Member domains
106
with ligand contacts (≤ 4 Å)
26.0% of members
110
with DrugDomain annotations
27.0% of members
58
with a DrugBank compound
14.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 206.1.1.2 belongs to X-group 206 Protein kinase/SAICAR synthase/ATP-grasp, which binds 10.2 ligand superclasses per 20 proteins, broader than 96% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB12010 | — | Fostamatinib | 12 |
| DB00171 | ATP | ATP | 3 |
| DB12369 | LW4 | Sotrastaurin | 3 |
| DB16833 | ADP | Adenosine disphosphate | 3 |
| DB00163 | — | Vitamin E | 2 |
| DB03247 | — | Flavin mononucleotide | 2 |
| DB05013 | — | — | 2 |
| DB06486 | — | — | 2 |
| DB06641 | — | — | 2 |
| DB07812 | G95 | N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide | 2 |
| DB08162 | M77 | Fasudil | 2 |
| DB08846 | — | Ellagic acid | 2 |
| DB11752 | — | — | 2 |
| DB12745 | G93 | GSK-690693 | 2 |
| DB14001 | — | — | 2 |
| DB14002 | — | — | 2 |
| DB15431 | 1SK | M-2698 | 2 |
| DB17058 | NM7 | TPCA-1 | 2 |
| DB00144 | — | Phosphatidyl serine | 1 |
| DB00173 | ADE | Adenine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MNmetal | MANGANESE (II) ION | 12 |
| CL | CHLORIDE ION | 9 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 6 |
| MGmetal | MAGNESIUM ION | 5 |
| 5FI | 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole | 4 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 4 |
| AFU | 2-amino-5-[3-(piperazin-1-yl)phenyl]-N-(pyridin-4-yl)pyridine-3-carboxamide | 4 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 4 |
| ZNmetal | ZINC ION | 4 |
| LW4 | 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-1H-pyrrole-2,5-dione | 3 |
| XOO | 4-{2-[({4-[(2P)-2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}methyl)amino]ethyl}-2-hydroxybenzaldehyde | 3 |
| 1RJ | 4-{[(1S)-1-(3-fluorophenyl)-2-(methylamino)ethyl]amino}quinazoline-8-carboxamide | 2 |
| 1SK | 4-({(1S)-2-(azetidin-1-yl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl}amino)quinazoline-8-carboxamide | 2 |
| 3L0 | (1R)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one | 2 |
| AF3 | ALUMINUM FLUORIDE | 2 |
| AMP | ADENOSINE MONOPHOSPHATE | 2 |
| C58 | (2S)-3-phenyl-N~1~-[2-(pyridin-4-yl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl]propane-1,2-diamine | 2 |
| G93 | 4-{2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methylbut-3-yn-2-ol | 2 |
| G95 | N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide | 2 |
| G96 | 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol | 2 |